Skip to content
healthcare.dev

Alert

NDC 55910-226, Caffeine, tablet, from DOLGENCORP, LLC.

Product NDC
55910-226
Status
Listed
Labeler
DOLGENCORP, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M011
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE200 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
55910-226-21559100226212 BLISTER PACK in 1 CARTON (55910-226-21) / 8 TABLET in 1 BLISTER PACK
55910-226-31559100226311 BOTTLE, PLASTIC in 1 CARTON (55910-226-31) / 80 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-226 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.